Scripps Wired for Health Monitoring Study

• ClinicalTrials.gov Identifier: NCT01975428
• Recruitment Status: Completed
• First Posted: November 3, 2013
• Results First Posted: July 7, 2021
• Last Update Posted: July 7, 2021
• Sponsor: Scripps Translational Science Institute
• Collaborator: Scripps Health
• Information provided by (Responsible Party): Eric Topol, MD, Scripps Translational Science Institute

Tracking Information

• First Submitted Date: October 17, 2012
• First Posted Date: November 3, 2013
• Results First Submitted Date: May 13, 2016
• Results First Posted Date: July 7, 2021
• Last Update Posted Date: July 7, 2021
• Study Start Date: November 2012
• Actual Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)

Current Primary Outcome Measures (submitted: July 2, 2021)

Participant Perceptions of Utility of Monitoring [ Time Frame: Measure at Day 180. ]

Multidimensional Health Locus of Control (Form C). Measure of the source of reinforcements for health-related behaviors: primarily internal, a matter of chance, or under the control of doctors, or other people. The scale includes 18 questions where responders indicate they strongly disagree (1), moderately disagree (2), slightly disagree (3), slightly agree (4), moderately agree (5), or strongly agree (6). Questions can be found here: https://nursing.vanderbilt.edu/projects/wallstonk/form_c.php. Subscale measures are summed over responses: questions 1, 6, 8, 12, 13, and 17 measure feeling of internal control (range 6-36); questions 2, 4, 9, 11, 15, 16 measure feeling of chance (range 6-36); questions 3, 5, 14 measure control of doctors (range 3-18); and questions 7, 10, and 18 measure control of others (range 3-18). Results presented using the 'Chance' subscale below.

Original Primary Outcome Measures (submitted: November 1, 2013)

Participant perceptions of utility of monitoring [ Time Frame: Change in perceptions from Day 1 to Day 180. ]

As this is a pilot study, primary endpoints will include participant perceptions of the utility of monitoring.

Current Secondary Outcome Measures (submitted: July 2, 2021)

Total Health Care Utilization and Costs. [ Time Frame: Total billed over 180 days. ]

Total health care utilization and costs in USD.

Original Secondary Outcome Measures (submitted: November 1, 2013)

Change in health care utilization and costs [ Time Frame: Change from Day 1 to Day 180. ]

Overall health care costs billed, as well as inpatient health service utilization (hospital admissions, days of hospitalization) and outpatient health service utilization (emergency department visits, need-based primary care clinic visits, and need-based specialty clinic visits). Investigators will also assess any increases/changes in medication use.

• Current Other Pre-specified Outcome Measures: Not Provided
• Original Other Pre-specified Outcome Measures: Not Provided

Descriptive Information

• Brief Title: Scripps Wired for Health Monitoring Study
• Official Title: Scripps Wired for Health Monitoring Study

Brief Summary

People with chronic diseases such as diabetes, hypertension (high blood pressure) and cardiac (heart) arrhythmias tend to go to the doctor more often and have more tests done than those without those diseases. This can lead to increasing costs of healthcare and extra visits to doctors and healthcare facilities.

There are now medical devices that can be used at home to monitor blood sugar, blood pressure, heart rhythms as well as other measurements. There have been some studies which show that when people take their own health readings, they are better able to control their disease, stay healthier and go to the doctor less often. In order to participate in the study participants will have been diagnosed with 1 or more of the following: Diabetes, Hypertension, Cardiac Arrhythmias.

This study is designed to test those devices and see if they can help participants stay healthier through the recording and tracking of health measurements. Investigators will also be testing how easy it is to use these devices and whether or how easy it is to fit them in their daily schedule. Participants will be given an iPhone for use during the study and their recordings will be stored and displayed on the phone.

Detailed Description

The study will evaluate the impact of a "Wireless Monitoring" intervention for chronically ill individuals with diabetes, hypertension, and arrhythmias. This project utilizes the concept of 'hot-spotting' in that investigators will aim to target individuals with the highest health care needs, which investigators have defined to be patients with these diagnoses who showed the highest health care utilization rates over the previous 12-month period based on reimbursement data from a large health care third party administrator. Investigators aim to determine if wireless monitoring can reduce health care service utilization and thus health care costs for the small number of patients who spend the greatest number of health care dollars, thereby cutting the overall amount of health care spending dramatically.

Furthermore, investigators will be assessing whether or not access to health measurement data and the possibility of receiving feedback from a study staff member will increase the compliance of patients to their medication regimen, recommended diet and exercise. It is anticipated that armed with their own health data, these patients will be less likely to need acute care visits

Study participants will be employees of Scripps Health or dependents of employees covered with Scripps insurance, administered by third-party administrator, Health Comp. In addition, patients will be currently enrolled or willing to enroll in Health Comp's Disease Management program. Investigators predict that in addition to participation in the program, wireless monitoring will be associated with decreased inpatient health service utilization (hospital admissions, days of hospitalization) and decreased outpatient health service utilization (emergency department visits, need-based primary care clinic visits, and need-based specialty clinic visits). Investigators predict that these decreases will translate into significant reductions in health care costs for the treatment group relative to a control group and relative to pre-monitoring utilization rates.

• Study Type: Interventional
• Study Phase: Not Applicable
• Study Design: Allocation: Randomized; Intervention Model: Parallel Assignment; Masking: None (Open Label); Primary Purpose: Health Services Research

Condition

• Diabetes
• Hypertension
• Cardiac Arrhythmia

Intervention

• Device: DM Pgm + device

  Disease management program plus a device corresponding to an individual's disease(s):

  iBGStar - iPhone enabled capillary blood glucose meter. Subjects test blood glucose up to 4 times per day, every day.

  Withings BP monitor - iPhone enabled home blood pressure monitor. Subjects test their blood pressure 2 times per day, up to 3 days per week.

  iPhone enabled Alive Cor ECG monitor. Participants take an ECG reading only when symptomatic.

• Behavioral: Control
  All study participants, including participants randomized to the control arm, were enrolled in the HealthComp disease management program, which involved outreach by HealthComp nursing staff for purposes of relaying medical education and wellness information with regard to disease prevention and chronic disease management.

Study Arms

• Control
  All study participants, including participants randomized to the control arm, were enrolled in the HealthComp disease management program, which involved outreach by HealthComp nursing staff for purposes of relaying medical education and wellness information with regard to disease prevention and chronic disease management.
  Intervention: Behavioral: Control
• Active Comparator: DM Pgm + device

  Disease management (DM) program plus a device corresponding to an individual's disease(s):

  iBGStar - iPhone enabled capillary blood glucose meter. Subjects test blood glucose up to 4 times per day, every day.

  Withings BP monitor - iPhone enabled home blood pressure monitor. Subjects test their blood pressure 2 times per day, up to 3 days per week.

  iPhone enabled Alive Cor ECG monitor. Participants take an ECG reading only when symptomatic.

  Intervention: Device: DM Pgm + device

• Publications *: Kim JY, Wineinger NE, Steinhubl SR. The Influence of Wireless Self-Monitoring Program on the Relationship Between Patient Activation and Health Behaviors, Medication Adherence, and Blood Pressure Levels in Hypertensive Patients: A Substudy of a Randomized Controlled Trial. J Med Internet Res. 2016 Jun 22;18(6):e116. doi: 10.2196/jmir.5429.

Recruitment Information

• Recruitment Status: Completed
• Actual Enrollment (submitted: July 2, 2021): 182
• Original Estimated Enrollment (submitted: November 1, 2013): 200
• Actual Study Completion Date: December 2014
• Actual Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)

Eligibility Criteria

Inclusion Criteria:

1. Scripps Health insured employee or adult family member
2. Internet access and e-mail
3. Provide permission for study staff to access medical records
4. Participating in Health Comp Disease Management program or willingness to join
5. English speaking
6. Within the past 12 months, a history of billing insurance for diagnostic codes consistent with diabetes, hypertension, and/or cardiac arrhythmia
7. 18 years and older
8. Willingness to use wireless devices and study iPhone

Exclusion Criteria:

1. Employee of Scripps Clinic Medical Group
2. Related to or household sharing with another study participant (if there are two people or more in one household that are eligible, the member that has the highest utilization will be invited to join first)
3. Unwilling or unable to grant informed consent
4. Pregnancy

Sex/Gender

• Sexes Eligible for Study: All

• Ages: 18 Years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Contacts: Contact information is only displayed when the study is recruiting subjects
• Listed Location Countries: United States

Administrative Information

• NCT Number: NCT01975428
• Other Study ID Numbers: Scripps WFH Study
• Has Data Monitoring Committee: No
• U.S. FDA-regulated Product: Not Provided
• IPD Sharing Statement: Not Provided
• Current Responsible Party: Eric Topol, MD, Scripps Translational Science Institute
• Original Responsible Party: Same as current
• Current Study Sponsor: Scripps Translational Science Institute
• Original Study Sponsor: Same as current
• Collaborators: Scripps Health

Investigators

• Principal Investigator: Eric J Topol, MD; Scripps Translational Science Institute

• PRS Account: Scripps Translational Science Institute
• Verification Date: July 2021